[1] Roberts A E, Allanson J E, Tartaglia M, Gelb B D. Noonan syndrome. Lancet, 2013, 381(9863): 333-342.
[2] Shoji Y, Ida S, Niihori T, Aoki Y, Okamoto N, Etani Y, Kawai M. Genotype-phenotype correlation analysis in Japanese patients with Noonan syndrome. Endocr J, 2019, 66(11): 983-994.
[3] Li X, Yao R, Tan X, Li N, Ding Y, Li J, Chang G, Chen Y, Ma L, Wang J, Fu L, Wang X. Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients. Clin Genet, 2019, 96(4): 290-299.
[4] Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in RASopathies. J Hum Genet, 2016, 61(1): 33-39.
[5] Yamamoto G L, Aguena M, Gos M, Hung C, Pilch J, Fahiminiya S, Abramowicz A, Cristian I, Buscarilli M, Naslavsky M S, Malaquias A C, Zatz M, Bodamer O, Majewski J, Jorge A A, Pereira A C, Kim C A, Passos-Bueno M R, Bertola D R. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. J Med Genet, 2015, 52(6): 413-421.
[6] Piotrowski A, Xie J, Liu Y F, Poplawski A B, Gomes A R, Madanecki P, Fu C, Crowley M R, Crossman D K, Armstrong L, Babovic-Vuksanovic D, Bergner A, Blakeley J O, Blumenthal A L, Daniels M S, Feit H, Gardner K, Hurst S, Kobelka C, Lee C, Nagy R, Rauen K A, Slopis J M, Suwannarat P, Westman J A, Zanko A, Korf B R, Messiaen L M. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet, 2014, 46(2): 182-187.
[7] Chen P C, Yin J, Yu H W, Yuan T, Fernandez M, Yung C K, Trinh Q M, Peltekova V D, Reid J G, Tworog-Dube E, Morgan M B, Muzny D M, Stein L, McPherson J D, Roberts A E, Gibbs R A, Neel B G, Kucherlapati R. Next-generation sequencing identifies rare variants associated with Noonan syndrome. Proc Natl Acad Sci U S A, 2014, 111(31): 11473-11478.
[8] Chinton J, Huckstadt V, Mucciolo M, Lepri F, Novelli A, Gravina L P, Obregon M G. Providing more evidence on LZTR1 variants in Noonan syndrome patients. Am J Med Genet A, 2020, 182(2): 409-414.
[9] Evans D G, Bowers N L, Tobi S, Hartley C, Wallace A J, King A T, Lloyd S, Rutherford S A, Hammerbeck-Ward C, Pathmanaban O N, Freeman S R, Ealing J, Kellett M, Laitt R, Thomas O, Halliday D, Ferner R, Taylor A, Duff C, Harkness E F, Smith M J. Schwannomatosis: a genetic and epidemiological study. J Neurol Neurosurg Psychiatry, 2018, 89(11): 1215-1219.
[10] Paganini I, Chang V Y, Capone G L, Vitte J, Benelli M, Barbetti L, Sestini R, Trevisson E, Hulsebos T J, Giovannini M, Nelson S F, Papi L. Expanding the mutational spectrum of LZTR1 in schwannomatosis. Eur J Hum Genet, 2015, 23(7): 963-968.
[11] Pagnamenta A T, Kaisaki P J, Bennett F, Burkitt-Wright E, Martin H C, Ferla M P, Taylor J M, Gompertz L, Lahiri N, Tatton-Brown K, Newbury-Ecob R, Henderson A, Joss S, Weber A, Carmichael J, Turnpenny P D, McKee S, Forzano F, Ashraf T, Bradbury K, Shears D, Kini U, de Burca A, Blair E, Taylor J C, Stewart H. Delineation of dominant and recessive forms of LZTR1-associated Noonan syndrome. Clin Genet, 2019, 95(6): 693-703.
[12] Johnston J J, van der Smagt J J, Rosenfeld J A, Pagnamenta A T, Alswaid A, Baker E H, Blair E, Borck G, Brinkmann J, Craigen W, Dung V C, Emrick L, Everman D B, van Gassen K L, Gulsuner S, Harr M H, Jain M, Kuechler A, Leppig K A, McDonald-McGinn D M, Can N, Peleg A, Roeder E R, Rogers R C, Sagi-Dain L, Sapp J C, Schaffer A A, Schanze D, Stewart H, Taylor J C, Verbeek N E, Walkiewicz M A, Zackai E H, Zweier C, Zenker M, Lee B, Biesecker L G. Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants. Genet Med, 2018, 20(10): 1175-1185.
[13] El B I, Belhassan K, Moufid F Z, Iraqui H M, Bouguenouch L, Samri I, Atmani S, Ouldim K. Noonan syndrome-causing genes: Molecular update and an assessment of the mutation rate. Int J Pediatr Adolesc Med, 2016, 3(4): 133-142.
[14] Yamamoto G L, Aguena M, Gos M, Hung C, Pilch J, Fahiminiya S, Abramowicz A, Cristian I, Buscarilli M, Naslavsky M S, Malaquias A C, Zatz M, Bodamer O, Majewski J, Jorge A A, Pereira A C, Kim C A, Passos-Bueno M R, Bertola D R. Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. J Med Genet, 2015, 52(6): 413-421.
[15] Perin F, Trujillo-Quintero J P, Jimenez-Jaimez J, Rodriguez-Vazquez D R M, Monserrat L, Tercedor L. Two novel cases of autosomal recessive Noonan syndrome associated with LZTR1 variants. Rev Esp Cardiol (Engl Ed), 2019.
[16] Li-ping H, Zhe S U, Wei C, Hong-tao Q I, Li W, Li Z. Measurements of physical symmetry indexes for healthy children in Shenzhen aged 6~ 13 years old. Chinese Journal of Child Health Care, 2017, 25(8): 815-817.
[17] Allanson J E, Roberts A E. Noonan Syndrome. 1993.
[18] McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, DePristo M A. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res, 2010, 20(9): 1297-1303.
[19] DePristo M A, Banks E, Poplin R, Garimella K V, Maguire J R, Hartl C, Philippakis A A, Del A G, Rivas M A, Hanna M, McKenna A, Fennell T J, Kernytsky A M, Sivachenko A Y, Cibulskis K, Gabriel S B, Altshuler D, Daly M J. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet, 2011, 43(5): 491-498.
[20] Van der Auwera G A, Carneiro M O, Hartl C, Poplin R, Del A G, Levy-Moonshine A, Jordan T, Shakir K, Roazen D, Thibault J, Banks E, Garimella K V, Altshuler D, Gabriel S, DePristo M A. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics, 2013, 43: 10-11.
[21] Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody W W, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm H L. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med, 2015, 17(5): 405-424.
[22] Breilyn M S, Mehta L. Clinical Manifestations of Noonan Syndrome and Related Disorders. Pediatr Endocrinol Rev, 2019, 16(Suppl 2): 428-434.
[23] Li X, Yao R, Tan X, Li N, Ding Y, Li J, Chang G, Chen Y, Ma L, Wang J, Fu L, Wang X. Molecular and phenotypic spectrum of Noonan syndrome in Chinese patients. Clin Genet, 2019, 96(4): 290-299.
[24] Jacquinet A, Bonnard A, Capri Y, Martin D, Sadzot B, Bianchi E, Servais L, Sacre J P, Cave H, Verloes A. Oligo-astrocytoma in LZTR1-related Noonan syndrome. Eur J Med Genet, 2019.
[25] Yart A, Edouard T. Noonan syndrome: an update on growth and development. Curr Opin Endocrinol Diabetes Obes, 2018, 25(1): 67-73.
[26] Allen M J, Sharma S. Noonan Syndrome. 2020.
[27] Bigenzahn J W, Collu G M, Kartnig F, Pieraks M, Vladimer G I, Heinz L X, Sedlyarov V, Schischlik F, Fauster A, Rebsamen M, Parapatics K, Blomen V A, Muller A C, Winter G E, Kralovics R, Brummelkamp T R, Mlodzik M, Superti-Furga G. LZTR1 is a regulator of RAS ubiquitination and signaling. Science, 2018, 362(6419): 1171-1177.
[28] Steklov M, Pandolfi S, Baietti M F, Batiuk A, Carai P, Najm P, Zhang M, Jang H, Renzi F, Cai Y, Abbasi A L, Pastor T, De Troyer M, Simicek M, Radaelli E, Brems H, Legius E, Tavernier J, Gevaert K, Impens F, Messiaen L, Nussinov R, Heymans S, Eyckerman S, Sablina A A. Mutations in LZTR1 drive human disease by dysregulating RAS ubiquitination. Science, 2018, 362(6419): 1177-1182.
[29] Aoki Y. [RASopathies and hematologic abnormalities]. Rinsho Ketsueki, 2015, 56(10): 2240-2247.
[30] Umeki I, Niihori T, Abe T, Kanno S I, Okamoto N, Mizuno S, Kurosawa K, Nagasaki K, Yoshida M, Ohashi H, Inoue S I, Matsubara Y, Fujiwara I, Kure S, Aoki Y. Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes. Hum Genet, 2019, 138(1): 21-35.
[31] Motta M, Fidan M, Bellacchio E, Pantaleoni F, Schneider-Heieck K, Coppola S, Borck G, Salviati L, Zenker M, Cirstea I C, Tartaglia M. Dominant Noonan syndrome-causing LZTR1 mutations specifically affect the Kelch domain substrate-recognition surface and enhance RAS-MAPK signaling. Hum Mol Genet, 2019, 28(6): 1007-1022.
[32] Wakula P, Beullens M, Ceulemans H, Stalmans W, Bollen M. Degeneracy and function of the ubiquitous RVXF motif that mediates binding to protein phosphatase-1. J Biol Chem, 2003, 278(21): 18817-18823.
[33] Ferreira M, Beullens M, Bollen M, Van Eynde A. Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics. Biochim Biophys Acta Mol Cell Res, 2019, 1866(1): 16-30.
[34] Cohen P T. Protein phosphatase 1--targeted in many directions. J Cell Sci, 2002, 115(Pt 2): 241-256.
[35] Liu R, Miller C, D'Annibale C, Vo K, Jacobs A. Differential localizations of protein phosphatase 1 isoforms determine their physiological function in the heart. Acta Biochim Biophys Sin (Shanghai), 2019, 51(3): 323-330.
[36] Nakaguma M, Jorge A, Arnhold I. Noonan syndrome associated with growth hormone deficiency with biallelic LZTR1 variants. Genet Med, 2019, 21(1): 260.